41 research outputs found

    The VIMOS Public Extragalactic Redshift Survey (VIPERS) : The decline of cosmic star formation: quenching, mass, and environment connections

    Get PDF
    RT acknowledges financial support from the European Research Council through grant n. 202686.We use the final data of the VIMOS Public Extragalactic Redshift Survey (VIPERS) to investigate the effect of the environment on the evolution of galaxies between z = 0.5 and z = 0.9. We characterise local environment in terms of the density contrast smoothed over a cylindrical kernel, the scale of which is defined by the distance to the fifth nearest neighbour. This is performed by using a volume-limited sub-sample of galaxies complete up to z = 0.9, but allows us to attach a value of local density to all galaxies in the full VIPERS magnitude-limited sample to i < 22.5. We use this information to estimate how the distribution of galaxy stellar masses depends on environment. More massive galaxies tend to reside in higher-density environments over the full redshift range explored. Defining star-forming and passive galaxies through their (NUV-r) vs. (r-K) colours, we then quantify the fraction of star-forming over passive galaxies, fap, as a function of environment at fixed stellar mass. fap is higher in low-density regions for galaxies with masses ranging from log (M/M⊙) = 10.38 (the lowest value explored) to at least log (M/M⊙) ~ 11.3, although with decreasing significance going from lower to higher masses. This is the first time that environmental effects on high-mass galaxies are clearly detected at redshifts as high as z ~ 0.9. We compared these results to VIPERS-like galaxy mock catalogues based on a widely used galaxy formation model. The model correctly reproduces fap in low-density environments, but underpredicts it at high densities. The discrepancy is particularly strong for the lowest-mass bins. We find that this discrepancy is driven by an excess of low-mass passive satellite galaxies in the model. In high-density regions, we obtain a better (although not perfect) agreement of the model fap with observations by studying the accretion history of these model galaxies (that is, the times when they become satellites), by assuming either that a non-negligible fraction of satellites is destroyed, or that their quenching timescale is longer than ~ 2 Gyr.PostprintPeer reviewe

    The VIMOS Public Extragalactic Redshift Survey (VIPERS). Downsizing of the blue cloud and the influence of galaxy size on mass quenching over the last eight billion years

    Get PDF
    R.T. acknowledges financial support from the European Research Councilthrough grant No. 202686.We use the full VIPERS redshift survey in combination with SDSS-DR7 to explore the relationships between star-formation history (using d4000), stellar mass and galaxy structure, and how these relationships have evolved since z ~ 1. We trace the extents and evolutions of both the blue cloud and red sequence by fitting double Gaussians to the d4000 distribution of galaxies in narrow stellar mass bins, for four redshift intervals over 0 < z < 1. This reveals downsizing in star formation, since the high-mass limit of the blue cloud has retreated steadily from time from ℳ ~ 1011.2 M⊙ at z ~ 0.9 to ℳ ~ 1010.7 M⊙ to the present day. The number density of massive blue-cloud galaxies (ℳ ~ 1011 M⊙, d4000 < 1.55) drops sharply by a factor five between z ~ 0.8 and z ~ 0.5. These galaxies are becoming quiescent at a rate that largely matches  the increase in the numbers of massive passive galaxies seen over this period. We examine the size-mass relation of blue-cloud galaxies,  finding that its high-mass boundary runs along lines of constant ℳ /re or equivalently inferred velocity dispersion. Larger galaxies can continue to form stars to higher stellar masses than smaller galaxies. As  blue-cloud galaxies approach this high-mass limit, entering a narrow diagonal region within the size-mass plane termed the “quenching zone”, they start to be quenched, their d4000 values increasing to push them towards the green valley. In parallel, their structures change, showing higher SĂ©rsic indices and central stellar mass densities. For these galaxies, bulge growth is required for them to reach the high-mass limit of the blue cloud and be quenched by internal mechanisms. The blue-cloud galaxies that are being quenched at z ~ 0.8 lie along the same size-mass relation as present day quiescent galaxies and seem the likely progenitors of today’s S0s.Publisher PDFPeer reviewe

    Acquired angioedema

    Get PDF
    Acquired angioedema (AAE) is characterized by acquired deficiency of C1 inhibitor (C1-INH), hyperactivation of the classical pathway of human complement and angioedema symptoms mediated by bradykinin released by inappropriate activation of the contact-kinin system. Angioedema recurs at unpredictable intervals, lasts from two to five days and presents with edema of the skin (face, limbs, genitals), severe abdominal pain with edema of the gastrointestinal mucosa, life-threateing edema of the upper respiratory tract and edema of the oral mucosa and of the tongue. AAE recurs in association with various conditions and particularly with different forms of lymphoproliferative disorders. Neutralizing autoantibodies to C1-INH are present in the majority of patients. The therapeutic approach to a patient with AAE should first be aimed to avoid fatalities due to angioedema and then to avoid the disability caused be angioedema recurrences. Acute attacks can be treated with plasma-derived C1-INH, but some patients become non-responsive and in these patients the kallikrein inhibitor ecallantide and the bradykinin receptor antagonist icatibant can be effective. Angioedema prophylaxis is performed using antifibrinolytic agents and attenuated androgens with antifibrinolytic agents providing somewhat better results. Treatment of the associated disease can resolve AAE in some patients

    Sardinia Array Demonstrator: Instrument Overview and Status

    Get PDF
    In the framework of the Square Kilometer Array (SKA) project, the Italian Institute for Astrophysics (INAF) has addressed several efforts in the design and prototyping of aperture arrays for low-frequency radio astronomical research. The Sardinia Array Demonstrator (SAD) is a national project aimed to develop know-how in this area and to test different architectural technologies and calibration algorithms. SAD consists of 128 prototypical dual-polarized Vivaldi antennas designed to operate at radio frequencies below 650 MHz. The antennas will be deployed at the Sardinia Radio Telescope’s site with a versatile approach able to provide two different array configurations: (i) all antennas grouped in one large station or (ii) spread among a core plus few satellite stations. This paper provides an overview of the SAD project from an instrumental point of view, and illustrates its status after 2 years from its start

    The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update

    Get PDF
    Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1 inhibitor (type 1) and HAE with dysfunctional C1 inhibitor (type 2), by providing guidance on common and important clinical issues, such as: (1) How should HAE be diagnosed? (2) When should HAE patients receive prophylactic on top of on-demand treatment and what treatments should be used? (3) What are the goals of treatment? (4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast-feeding women? and (5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients

    The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.

    Get PDF
    Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1-inhibitor (type 1) and HAE with dysfunctional C1-inhibitor (type 2), by providing guidance on common and important clinical issues, such as: 1) How should HAE be diagnosed? 2) When should HAE patients receive prophylactic on top of on-demand treatment and what treatments should be used? 3) What are the goals of treatment? 4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast feeding women? 5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients

    Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence

    Get PDF

    Differential diagnosis and management issues of idiopathic angiooedema and their resolution

    No full text
    Angiooedema is a local and self-limiting swelling of the subcutaneous and sub mucosal tissues, produced by vasoactive peptides that temporary increase the vascular permeability

    Evaluation of electric field profile and transport parameters in solid-state CZT detectors

    No full text
    Electric field profile and transport parameters from independent measurements on planar CdZnTe spectroscopic detectors were compared. The mobility and lifetime for electrons, together with the electric field profile, were deduced from current transient profiles induced by laser pulses at different applied voltages. The method is founded on a procedure of minimization built up from the Ramo-Shockley theorem and some physical constraints. The procedure was tested on a planar detector built with spectroscopic CdZnTe grown at IMEM-CNR in Parma, Italy. The mobility-lifetime product was also evaluated by fitting the charge collection efficiency curves under a suitable electric field profile model. Comparison between results from both the techniques are in good agreement and confirm the high spectroscopic features of the investigated material
    corecore